This inventor holds 1 USPTO granted patent. Top assignees: Lg Life Sciences, Limited, Yamanouchi Pharmaceutical Company Ltd.. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 75 
1 out of 329 Years Active: 2011
Title: Hiroyuki Ito: Innovator in Melanocortin Receptor Agonists
Introduction
Hiroyuki Ito is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmacology, particularly through his work on melanocortin receptor agonists. His innovative approach has led to the development of a compound that has potential therapeutic applications.
Latest Patents
Hiroyuki Ito holds a patent for melanocortin receptor agonists. The patent describes a compound of formula 1, along with its pharmaceutically acceptable salt, hydrate, solvate, or isomer. This compound is effective as an agonist of the melanocortin receptor and is part of an agonistic composition that includes the same as an active ingredient.
Career Highlights
Throughout his career, Hiroyuki Ito has worked with prominent companies in the pharmaceutical industry. He has been associated with LG Life Sciences and Yamanouchi Pharmaceutical Company Limited, where he contributed to various research and development projects.
Collaborations
Hiroyuki Ito has collaborated with notable colleagues, including Koo Lee and Heui-Sul Park. Their combined expertise has likely enhanced the research and development efforts in their respective fields.
Conclusion
Hiroyuki Ito's work on melanocortin receptor agonists showcases his innovative spirit and dedication to advancing medical science. His contributions are valuable to the pharmaceutical industry and have the potential to impact therapeutic practices significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile